This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada Expert Interview with
Michael C. Riddell, PhD

Suzanne Lepage, a private health plan strategist with over 20 years in the
group insurance industry, is joined by Michael C. Riddell, PhD, Professor,
School of Kinesiology and Health Science, Faculty of Health, York University
diabetes registry recently published in Diabetic Medicine.

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.

Featured Article

CGM use Lowers Hospitalizations, may Reduce Mortality in Type 1 and Type 2 Diabetes

New Video Resource

Diabetes Canada Clinical Practice Guidelines:
Recommendations for
Continuous Glucose Monitoring (CGM)

Click Here to Watch Now

Featured Conference Update

Latest Research in Diabetes Technology:
Highlights from ATTD 2022

Featured Update

2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes

Featured Publication

Comparing real-time and intermittently scanned continuous glucose monitoring in adults
with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized
controlled trial [Summary]

Mother relieved RAMQ will now cover essential medical device

Mother relieved RAMQ will now cover essential medical deviceCBC News – May 26, 2021